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Parkinson diseaseP-type ion pumps are membrane transporters that have been classiﬁed into ﬁve subfamilies termed P1–P5. The
ion transported by the P5-ATPases is not known. Five genes named ATP13A1–ATP13A5 that belong to the P5-
ATPase group are present in humans. Loss-of-function mutations in the ATP13A2 gene (PARK9, OMIM 610513)
underlay a form of Parkinson's disease (PD) known as the Kufor–Rakeb syndrome (KRS), which belongs to the
group of syndromes of neurodegeneration with brain iron accumulation (NBIA).
Herewe report that the cytotoxicity induced by iron exposurewas two-fold reduced in CHO cells stably express-
ing the ATP13A2 recombinant protein (ATP13A2). Moreover, the iron content in ATP13A2 cells was lower than
control cells stably expressing an inactivemutant of ATP13A2. ATP13A2 expression caused an enlargement of ly-
sosomes and late endosomes. ATP13A2 cells exhibited a reduced iron-induced lysosome membrane perme-
abilization (LMP). These results suggest that ATP13A2 overexpression improves the lysosome membrane
integrity and protects against the iron-induced cell damage.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
P-type ATPases are characterized by the formation of a phosphory-
lated intermediate during their reaction cycle and are involved in the
active transport of inorganic cations and other substrates across cell
membranes. This superfamily is phylogenetically divided into ﬁve sub-
families termed P1–P5 or type I-V [1]. The P5 subfamily is expressed
only in eukaryotes and their substrate speciﬁcity is not known [2,3]. In
humans, there were identiﬁed ﬁve genes named ATP13A1–ATP13A5
that belong to this group of P5-ATPases [3]. Two P5-ATPases named
Cod1p (or Spf1p) and Ypk9p were found in the yeast Saccharomyces
cerevisiae. By DNA sequence alignment, it was shown that this type V
ATPases must be divided in two groups named P5A and P5B; the mouse
gene Atp13a1 and the yeast gene coding Cod1p (Yel031w) are members
of the ﬁrst group, while the mouse genes Atp13a2–Atp13a5 and the
yeast gene coding Ypk9p (Yor291w) are clustered into the second one
(1). P5A-ATPases have been identiﬁed in the endoplasmic reticulum
and seem to have basic functions in protein maturation and secretion,
while P5B ATPases localize to vacuolar/lysosomal or apical membranes
and in animals play a role in hereditary neuronal diseases [4–7]. Loss-
of-function mutations of the human gene ATP13A2 were found toCS, fetalcalf serum;MTT,3-(4,5-
ide
ax: +54 11 4962 5457.
o), ftpinto@qb.ffyb.uba.ar (F. deunderlie an autosomal recessive form of early-onset parkinsonism
(Kufor–Rakeb Syndrome) [6], which was recently proposed to be
a type of neurodegeneration with brain iron accumulation (NBIA)
[8,9].
Iron cycles easily between oxidized ferric Fe(III) and reduced ferrous
Fe(II) and readily forms complexes with oxygen, making this metal a
central player in respiration and related redox processes. However,
free or redox-active iron is also associated with harmful processes be-
cause Fe(II) can react with oxygen (O2) to form superoxide (O2•-).
More importantly, Fe(II) can also homolytically cleave hydrogen perox-
ide (H2O2) yielding hydroxyl radicals (HO•) and hydroxyl ions (OH–)
(Fenton-type reaction). HO• is a particularly aggressive, oxidative, and
short-lived species that reacts directly where it is formed. Superoxide
is not a powerful oxidant but has the capacity to reduce Fe (III) to
Fe(II), thereby initiating the production of the much more destructive
HO•. Inside the lysosomal compartment, redox-active iron is formed
when liberated following autophagic degradation, creating Fenton-
type reactions with hydrogen peroxide that may diffuse from the cyto-
sol. As a consequence, lysosomemembranemay be destabilized by per-
oxidation of adjacent lipids or accumulate the age pigment lipofuscin
with depression of autophagic capacity [10,11]. This damage is lessened
by intralysosomal mechanisms that keep iron in bound form.
In this paper, we have investigated the sensitivity to FeCl3 of CHO
cells expressing the human P5B-ATP13A2 wild type (ATP13A2) or a mu-
tant in which the catalytic residue Asp 508 was substituted by Asn
(ATP13A2-D508N) [12–14]. As expected, CHO cells mortality increased
with increasing concentrations of FeCl3; however, we found that the cy-
totoxic effect was reduced in the cells expressing the active ATP13A2 in
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largement of lysosomes and late endosomes and increased the stability
of lysosomes membranes toward the iron-induced permeabilization.
These results support the idea that the expression of ATP13A2 protects
CHO cells from iron-induced damage by stabilizing the lysosome
integrity.
2. Materials and methods
2.1. Materials
Reagents were purchased from Life Technologies, and reagents
for cell culture, dithiothreitol (DTT), ferric chloride (FeCl3),
phenylmethanesulfonyl ﬂuoride (PMSF), chloroquine (CQ), N-acetyl-
cysteine (NAC), and other chemicals, Sigma.
2.2. Cell culture and protein expression
Stable CHO cell lines transfected with the empty vector (pcDNA3.1)
or expressing the recombinants human ATP13A2 (ATP13A2) or mutant
ATP13A2-D508N (ATP13A2-D508N) were described previously [12–14].
The detection of the recombinant proteins was performed by immuno-
blotting using the antibody to ATP13A2 (Sigma). The cells were main-
tained in Dulbecco's modiﬁed Eagle medium supplemented with
0.1 mM hypoxanthine, 0.01 mM thymidine, 300 μg/ml geneticin
(G418), 100 U/ml penicillin, 100 μg/ml streptomycin, and 10% fetal
calf serum (FCS). The cells were grown in humidiﬁed 5% CO2/air on
standard plastic culture dishes.
2.3. Cell viability assay
CHO cells (2 × 104/well in 100 μl) were plated in 96-well micro-
plates and incubated in thementioned conditions. Themediumwas re-
moved 24–48 h later, and the cells were washed and incubated in
complete medium with increasing concentrations of FeCl3, or with
1.5 mM FeCl3 plus 0 or 5 mM N-acetyl-cysteine (NAC). The viability
assay was performed the following day by measuring the activity of
the lysosome enzyme β-hexosaminidase as described previously
[13–15]. Because β-hexosaminidase is a lysosomal enzyme and its ac-
tivity could be affected by the expression of the ATP13A2 protein in
the same organelle, we validated our viability results also using the
MTT (Sigma) assay.
2.4. Cell iron measurement
Cell iron content was measured quantitatively by the colorimetric
ferrozine-based assay [16] and qualitatively by Perls' Prussian blue
stain [17]. For theﬁrstmethod, CHO cellswere seeded in 24-well culture
plates with initial density of 5 × 104 cells per well and grown for 48 h as
mentioned. The cells werewashed twicewith Hank's solution and incu-
bated in complete medium with increasing concentrations of FeCl3 for
24 h. Iron accumulation was terminated by washing the cells three
times with 2 mL of ice-cold PBS. After completely removing the PBS,
the cells were frozen and the dishes were stored at−20 °C. Cells were
lysed with 200 μl of 50mMNaOH for 2 h on a shaker in a humidiﬁed at-
mosphere. Aliquots (100 μl) of cell lysates were placed in Eppendorf
tubes andmixedwith 100 μl of 10mMHCl (the solvent of the iron stan-
dard FeCl3) and 100 μl of the iron-releasing reagent (a freshlymixed so-
lution of equal volumes of 1.4 M HCl and 4.5% (w/v) KMnO4 in H2O).
These mixtures were incubated for 2 h at 60 °C within a fume hood
since chlorine gas is produced during the reaction. The HCl/KMnO4 pre-
treatment is sufﬁcient to release iron quantitatively from proteins, in-
cluding the iron-storage protein ferritin, and heme proteins such as
hemoglobin. After the mixtures had cooled to room temperature, 30 μl
of the iron-detection reagent (6.5 mM ferrozine, 6.5 mM neocuproine,
2.5 M ammonium acetate, and 1 M ascorbic acid dissolved in water)was added to each tube. After 30 min, 280 μl of the solution in each
tube was transferred into a well of a 96-well plate, and the absorbance
was measured at 550 nm in a Microplate Reader Model 2100C (Rayto,
Shenzhen, China). The iron content of the sample was calculated by
comparing its absorbance to that of a range of standard concentrations
of equal volume that had been prepared in a way similar to that of the
sample (mixture of 100 μl of FeCl3 standards (0–300 μM) in 10 mM
HCl, 100 μl 50 mM NaOH, 100 μl releasing reagent, and 30 μl detection
reagent). The intracellular iron concentration determined for each
well of a cell culture was normalized against the protein content of
that well. For this purpose, aliquots (5–20 μl) of the cell lysate were
transferred to 96-well microplates for protein determination by
means of the Bio-Rad protein assay, with bovine serum albumin as a
standard. The total iron content was expressed as nmol of iron per mil-
ligram of protein.
For Perls' staining, cells were plated (6 × 105 cells per well) on glass
coverslips and cultured as mentioned. After 48 h, they were incubated
in complete DMEM with 0.3 mM FeCl3. Iron exposure was terminated
24 h later by washing the cells twice with 1 mL of ice-cold PBS. The
cells were then ﬁxed with 4% paraformaldehyde in PBS, washed twice
with H2O, incubated in Perls' staining solution (comprising equal parts
of potassium ferrocyanide and HCl), washed 3 timeswith H2O, counter-
stained with Neutral Red (Sigma), dehydrated, cleared in xylene,
mounted using Dako Faramount Aqueous Mounting Medium, and ob-
served by light microscopy (Lieca DM2000, Microsystems, Wetzlar,
Germany).2.5. Cytosol fraction isolation
CHO cells were plated (2 × 106 cells/well in 10 ml) in 100 × 20 mm
cell culture dishes and incubated in the mentioned conditions. When
the cells reached conﬂuence the medium was removed, the cells were
washed twice with PBS and resuspended in PBS-EDTA 1 mM by scrap-
ing. The cells were pelleted by centrifugation (10000×g for 15 min at
4 °C) and homogenized in 3 ml of isotonic solution containing Tris–
HCl 10 mM (pH 7.4), KCl 0.15 M, 1 mMMgCl2, 0.25 M sucrose and the
protease inhibitors phenylmethanesulfonyl ﬂuoride (PMSF) 0.1 mM,
aprotinin 8 μg/ml and leupeptin 1 μg/ml. The homogenate was centri-
fuged at 12000×g for 10 min at 4 °C. The supernatant was transferred
to a new tube and centrifuged at 25000×g for 15 min at 4 °C to precip-
itate themitochondrial fraction. The supernatant was frozen in aliquots
at−80 °C and used as the isolated cytosol fraction for the determination
of the β-hexosaminidase activity. Protein concentration was estimated
by means of the Bio-Rad protein assay, with bovine serum albumin as
a standard.2.6. Fluorescence microscopy with acridine orange (AO)
The staining of the cells with AO for the ﬂuorescencemicroscopy as-
says was described previously [13]. Brieﬂy, the cells were cultured on
glass multiwell plates for 48–72 h, washed with PBS, and incubated
with the pH-sensitive ﬂuorescent dye AO (Sigma) 0.05 μM for 10 min.
The cells were then washed, and the living cells were directly observed
by confocal microscopy (FluoView 1000, Olympus, Japan) with an ap-
propriate AO ﬁlter. The digitized images were analyzed by using the
ImageJ Software program (NIH) to measure the mean vesicle area of
each image. Brieﬂy, the threshold was adjusted to take off the back-
ground and establish the lower ﬂuorescence limit detection; this pa-
rameter was the same for all the analyzed images. Finally, the Analyze
Particles routine of ImageJwasused, and the output tablewith the num-
ber and size of the vesicles was analyzed with Excel. Values are
expressed as the mean vesicle area obtained for each cell type. In each
case, at least 50 cells from three or four independent experiments
were scored.
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Cells were ﬁxed in 0.1 M sodium cacodylate trihydrate (pH 7.5) for
24 h. Then they were postﬁxed with 1.5% OsO4 and embedded in
Spurr resin after dehydration. Ultrathin sections (60 nm) were cut
with an ultramicrotome. The specimens were examined with a Zeiss
EM 109 T electron microscope, 80 kV (Zeiss Inc, Oberkochen,
Germany); images were acquired with a Gatan ES1000W (11Mega-
pixel) camera.
2.8. Lysosomal membrane permeability assays
Cells were assessed for lysosomal stability using the AO uptake and
relocation methods [18] and the cytoplasmic presence of the lysosomal
enzyme β-hexosaminidase [15].
2.8.1. The AO method
AO is a lysosomotropic base and a metachromatic ﬂuorochrome
exhibiting red ﬂuorescence when highly concentrated (as is the
case in intact lysosomes where AO is retained in its charged, AOH+,
form). And green ﬂuorescence at low concentration (as is the case
when some lysosomes have ruptured and AO relocates to the cytosol
where it occurs predominantly in the deprotonated form). The remain-
ing intact lysosomes were evaluated by assaying the red ﬂuorescence
(AO uptake method). However, because of the much higher sensitivity
of the photomultiplier to green than to red photons, this method is less
sensitive than following AO relocation within cells stained with AO
(AO relocationmethod). In some cases, early andminor lysosomal desta-
bilization were detected by the AO relocation method, while the AO up-
take method was observed in later and more pronounced lysosomal
rupture. CHO cells stably expressing the recombinants ATP13A2 or
ATP13A2-D508N pumps (8 × 104/well in 100 μl) were plated in 96-
well microplates and incubated in the mentioned conditions. After
48 h, the cells were exposed to 0.3 or 1.5 mM FeCl3 in complete growth
medium for 24 h or 1.5 h, respectively. Following FeCl3 treatment, AO
5 μg/ml was added and incubated for 10 min at 37 °C in the dark. The
cells were then washed three times with 200 μl PBS, 100 μl of complete
DMEM was added to the living cells and where then directly observed
by confocalmicroscopy (FluoView1000, Olympus, Japan). The excitation
wavelength was 473 nm, and the green and red ﬂuorescence emissions
were recorded between 509-562 nm and 630-693 nm, respectively. For
the enhance oxidative stress assay, the cellswere incubatedwith 0.3mM
FeCl3 in complete growth medium for 24 h, and 1.5 or 3 mM H2O2 was
added to the culture for 1 h before being stained with AO as mentioned
before.
For image quantiﬁcation, the digitized images were analyzed by
using the ImageJ Software program (NIH) to measure the mean red
ﬂuorescence intensity of all vesicles of each cell or the mean green ﬂuo-
rescence intensity of the whole cell. In each case, at least 20 cells from
four independent experiments were scored.
2.8.2. β-Hexosaminidase enzymatic assay
For the detection of the lysosomal enzyme β-hexosaminidase in the
cytosol, the cellswere incubatedwith 1.5mMFeCl3 for 1.5 h becausewe
obtained similar results as that observed by incubating with 0.3 mM
FeCl3 for 24 h when using the AO method. The cells were then rinsed
extensively with PBS and removed by scraping in the homogenization
buffer. The cytosolic fraction was isolated as described above. Fifty mi-
croliters of the isolated cytosol fraction was incubated with 60 μl sub-
strate solution (7.5 mM p-nitrophenol-N-acetyl-beta-D-glucosaminide
(Sigma), 0.1 M sodium citrate pH 5.0, and 0.25% Triton X-100) at 37 °C
with 100% humidity for 4 h. The colorimetric product was visualized
by adding 90 μl developer solution (50 mM glycine pH 10.4, 5 mM
EDTA) and quantiﬁed by recording the absorbance at 405 nm in a Mi-
croplate Reader Model 550 (Bio-Rad, Tokyo, Japan). β-hexosaminidase
activity was measured in duplicate. We normalized the activity of thelysosomal enzymeby correcting the activity in the cytosol of FeCl3 treat-
ed cells with the activity of untreated cells used as control.
2.9. Fluorescence imaging of F-actin cytoskeleton
Cells were plated (6 × 105) on glass coverslips and incubated in the
mentioned conditions. After 48 h, they were incubated with 1.5 mM
FeCl3 for 1.5 h at 37 °C. The cells were then ﬁxedwith 4% paraformalde-
hyde in PBS for 10min, permeabilized with 0.1% Triton X-100 in PBS for
10 min, washed three times with PBS, and incubated with 1 μg of
Phalloidin-TRITC conjugate (Sigma) per ml in PBS. Nuclei were stained
with 2.5 μM Hoechst 33258. Each coverslip was mounted in
SouthernBiotech Fluoromount-G™ Slide Mounting Medium and ob-
served by confocal microscopy (FluoView 1000, Olympus, Japan) with
an appropriate TRITC ﬁlter.
3. Results
3.1. ATP13A2-expressing cells are more resistant to FeCl3 treatment
The effect of FeCl3 on the viability of control CHO cells transfected
with the empty vector (pcDNA3.1), and cells expressing ATP13A2 or
the inactive mutant ATP13A2-D508N was investigated by measuring
the activity of the endogenous enzyme β-hexosaminidase. We have
previously shown that the recombinant proteins were expressed at
similar levels [13,14]; see Supplemental Fig. 1, available on the website
for more details. Fig. 1a shows the viability of CHO cells incubated for
24 h with increasing concentrations of FeCl3; as expected, the metal
exerts a dose-dependent cytotoxic effect. The exposure to 1 mM FeCl3
reduced the viability of CHO cells transfected with the empty vector
(pcDNA3.1) or expressing the ATP13A2-D508N at less than 60%.
Under the same conditions, near 90% of ATP13A2 cells remained viable,
indicating that the expression of ATP13A2made the cellsmore resistant
to iron treatment than CHO cells transfected with the empty vector or
expressing the ATP13A2-D508Nmutant pump. Similar results were ob-
tained by measuring the viability with the MTT method (data not
shown).
Since the toxic effect of iron is presumably related to oxidative stress,
CHO cells were treatedwith FeCl3 plus the antioxidantNAC. As depicted
in Fig. 1b, NAC protected the cells from the cytotoxic effect of iron
exposure.
3.2. Iron depositions are reduced in ATP13A2-expressing CHO cells
Because an accumulation of intracellular iron may induce cell death
by the generation of reactive oxygen species (ROS) through Fenton-type
reactions, we measured the iron content of CHO cells by the ferrozine
method. As shown in Fig. 2a, the iron accumulation increased gradually
with increasing concentrations of FeCl3 after 24 h treatment. ATP13A2-
D508N cells showed higher iron content than ATP13A2 cells at all FeCl3-
tested concentrations. This increment in the iron content in ATP13A2-
D508N cells varied from 20 to 55%, depending on the amount of FeCl3
added to the culture medium. Higher FeCl3 concentrations could not
be tested because of the insoluble precipitates formed by iron in the
presence of FCS.
The results were conﬁrmed by Perls' Prussian blue stain. In this
method, iron reacts with potassium ferrocyanide to form ferric ferrocy-
anide, the intensity of this insoluble, blue compound indicates qualita-
tively the iron amount. A non-toxic FeCl3 concentration was used in
order to minimize cell mortality and analyze an equal cell number in
each ﬁeld. As shown in Fig. 2b, control cells not exposed to FeCl3 show
no blue depositions. In contrast, insoluble blue sediments were ob-
served in cells exposed to 0.3 mM FeCl3 for 24 h. The intensity of the
blue precipitate was clearly much higher in pcDNA3.1 and ATP13A2-
D508N cells than in ATP13A2 cells.
Fig. 1. Viability of CHO cells transfected with the empty vector (pcDNA3.1) or stably ex-
pressing the ATP13A2 (ATP13A2) or ATP13A2-D508N (ATP13A2-D508N) pumps. (a) The
cells were incubated for 24 h at 37 °C with increasing concentrations of ferric chloride
(FeCl3). The viability assay was performed by measuring the activity of the endogenous
enzyme β-hexosaminidase as described in Section 2. Values are expressed as the percent-
age of the absorbance at 405 nmmeasured for untreated cells. Data are shown asmeans±
SEMof 4 independent experiments done by sextuplicate. The line represents the best ﬁt to
the data given by the following equation: viability = min + (max−min) / [1 + (FeCl3/
EC50)-Hillslope] (with min ≥ 0); with ATP13A2: min = 30 ± 135%, max = 102 ± 3%,
EC50 = 2.95 ± 6.03 mM, hillslope = 1.6 ± 1.3; ATP13A2-D508N: min = 52 ± 2%,
max = 101 ± 1%, EC50 = 0.59 ± 0.02 mM, hillslope = 5.3 ± 0.9; pcDNA3.1: min =
39 ± 6%, max = 101 ± 3%, EC50 = 0.61 ± 0.09 mM, hillslope = 1.8 ± 0.4. (b) Cells
were treated as in “a” with 1.5 mM FeCl3 plus 0 or 5 mM NAC for 24 h. The viability
assay was performed as mentioned before. A representative experiment from four inde-
pendent experiments is shownwhere each point is themean±SDof quadruplicate deter-
minations (***p b 0.001, signiﬁcantly different from NAC-treated cells). Statistical
signiﬁcance was assessed by one-way analysis of variance (ANOVA) followed by
Bonferroni post tests (GraphPad Prism 4, GraphPad Software, Inc.).
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ATP13A2
It has been shown that ATP13A2 co-localizeswith intracellular acidic
compartments, particularly lysosomes and endosomes [19], and that
the deﬁciency of ATP13A2 leads to lysosomal dysfunction [20,21]. The
lysosomal compartment consists of a large number of vacuoles with a
pronounced fusion and ﬁssion activity [22], and the lysosome degrada-
tion pathway inhibition alters iron metabolism and transport [11,23].
We evaluated the size of acidic vesicles by staining CHO cells with the
lysosomotropic agent AO. The autoﬂuorescent dye AO accumulates
mainly in the acidic vacuolar apparatus due to proton trapping. Fig. 3a
shows that larger vesicles were observed in ATP13A2-expressing cellswhen stained with AO. The image analysis indicated that the average
size of the acidic vesicles of ATP13A2 cells was 2-fold larger than
those from ATP13A2-D508N cells (Fig. 3b). This observation was also
conﬁrmed by electron microscopy (Fig. 3d). Strikingly, the observed
vesicles in ATP13A2-expressing cells were not only larger but also
showed more electron dense bodies resembling late autophagic
vacuoles-like structures [24].
The effect of the inhibitor of the intralysosomal catabolism chloro-
quine (CQ) was investigated. CQ is a known lysosomotropic agent that
increases lysosomal pH by accumulating within lysosomes as a
deprotonated weak base. CQ induces the dilation of lysosomes and the
accumulation of lipid bodies that may represent intracellular debris as
a consequence of dysfunctional lysosomes [25,26]. Besides, the dilation
of these vesicles allows us to observe them as individual entities. Fig. 3a
shows CHO cells exposed to 0.2mMCQ for 2 h and stainedwith 0.05 μM
AO. As expected, CQ treatment caused the dilation of the acidic vesicles,
but this increment was similar for ATP13A2 and ATP13A2-D508N cells
(Fig. 3c), showing that the acidic vesicles are larger in ATP13A2 cells
even in CQ absence.
3.4. Iron-induced lysosome membrane permeabilization (LMP) is reduced
in ATP13A2-expressing CHO cells
The production of highly reactive hydroxyl radicals from H2O2 by
intralysosomal iron-catalyzed Fenton-type reactions induces LMP
through lysosome membrane lipid peroxidation as one of the ﬁrst
events induced by iron overload [23,27–31]. Because ATP13A2 is
expressed in the membrane of this organelle, we hypothesized that
this enzyme may affect this process. Consequently, we investigated
the iron-induced LMP in CHO cells by assessing the changes in green
and red ﬂuorescence of cells stained with AO before and after the expo-
sure to FeCl3, respectively. Due to its metachromatic properties, AO
emits red ﬂuorescence inside the lysosomes, where it is highly concen-
trated, and emits weakly green ﬂuorescence in the cytosol and nucleus,
where its concentration is lower. Consequently, an increased cytosolic
green ﬂuorescence, due to AO leak from damaged lysosomes and a de-
cline in red ﬂuorescence from lysosomes are markers of the loss of lyso-
somalmembrane integrity.We used a relative low iron concentration of
0.3mM thatminimally affects viability in order to detect subtle changes
in membrane permeability which characterizes the initial steps of the
iron cytotoxic process. Fig. 4a shows ATP13A2 or ATP13A2-D508N
cells stained with AO after FeCl3 exposure. An increase in green ﬂuores-
cence (Fig. 4b) and a decreased in red ﬂuorescence (Fig. 4c) is observed
when AO is released from lysosomes into the cytosol due to iron treat-
ment. By comparison of ﬁgures obtained from ATP13A2 or ATP13A2-
D508N cells, it can be seen that the iron-induced LMP was greater in
ATP13A2-D508N cells than in ATP13A2 cells. The protection from the
iron-induced LMP conferred from ATP13A2 expression was indepen-
dently conﬁrmed by measuring the activity of the lysosome-resident
β-hexosaminidase released in the cytosol fraction from permeabilized
lysosomes. Fig. 4d shows the β-hexosaminidase activity of the cytosolic
fraction isolated from ATP13A2 and ATP13A2-D508N of FeCl3-treated
cells. The lysosome-resident enzyme activity was about 30% lower in
cells expressing ATP13A2 compared with those expressing ATP13A2-
D508N.
Since intralysosomal iron-catalyzed oxidative processes led to lyso-
somal rupture [32], we further challenged the iron-protection exerted
by ATP13A2 expression by using a free radical generator, such as hydro-
gen peroxide. To test this, we treated CHO cells overexpressing the re-
combinant proteins for 24 h with 0.3 mM FeCl3 and 1.5 or 3 mM H2O2
was added to the culture medium for 1 h before the AO staining as de-
scribed before. As shown in Fig. 4c, the treatment of CHO cells with
FeCl3 plus H2O2 further decreased the red punctuate ﬂuorescence in a
concentration dependent manner (see Fig. 4b, right panels with 1.5 and
3 mM H2O2). Nevertheless, by comparison of panels showing CHO cells
treated with FeCl3 plus 1.5 mM H2O2, ATP13A2-expressing cells were
Fig. 2. Iron contentmeasurement ofATP13A2 andATP13A2-D508N cells. The cellswere treatedwith the indicated FeCl3 concentrations for 24h, and the iron accumulationwasmeasuredby
(a) the colorimetric ferrozine-based assay or by (b) Perls' Prussian Blue staining (blue, iron stain; pink, nuclear–cytoplasmic counterstain). CHO cells transfected with the empty vector
(pcDNA3.1) were included as another control. Bar, 50 μm. A representative experiment from three independent experiments is shown in “a”where each point is the mean ± SD of trip-
licate determinations. **p b 0.01 and *p b 0.1 signiﬁcantly different from ATP13A2-expressing CHO cells (Student's t test, GraphPad Prism 4, GraphPad Software, Inc.).
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ﬂuorescence. Accordingly, ATP13A2-D508N cells were more susceptible
to the damaging effect of FeCl3 and 3 mM H2O2 as suggested by the al-
most imperceptible “punctuate” red ﬂuorescence and the gain in cyto-
plasmic red ﬂuorescence denoting the loss of lysosomal integrity.
3.5. ATP13A2 expression protects against the iron-induced actin cytoskele-
ton remodeling
Cathepsins, hydrolases, H+, and Ca2+ [28,31,33] can escape into the
cytosol as a consequence of LMP. The leakage of lysosome content leads
to actin cytoskeleton reorganization [34]. The ability of iron to stimulate
the reorganization of actin in CHO cells was assessed by ﬂuorescence
microscopy of F-actin stained with Phalloidin-TRITC conjugate
(Sigma). As shown in Fig. 5, untreated control cells had typical cellular
morphology with a well-deﬁned actin cytoskeleton. In contrast,
ATP13A2-D508N cells became rounded and exhibited a less organized
actin cytoskeleton after FeCl3 treatment. Noteworthy, in ATP13A2
cells, the iron-induced changes in the actin cytoskeleton were almost
undetectable.4. Discussion
Iron is found in high concentration in some areas of the brain, and
increased accumulation of iron in the substantia nigra is a feature of
PD. KRS is a form of Parkinson due to ATP13A2 gene mutations,
which was recently included in the group of syndromes of neurode-
generation with brain iron accumulation (NBIA) [9]. Here we report
that the overexpression of a functional ATP13A2 makes CHO cells
more resistant to FeCl3 exposure. Accordingly, the increase of iron
depositions due to FeCl3 treatment was diminished by ATP13A2
expression.
Lysosomes engaged in degrading iron-rich compounds are rich in
potentially redox-active iron, while resting lysosomes may contain no
iron at all. These iron-rich lysosomes are sensitive to oxidative stress,
and the magnitude of oxidative stress determines the degree of lyso-
somal destabilization and, consequently, whether arrested growth, re-
parative autophagy, apoptosis, or necrosis will follow. Namely, there is
a range in the iron level which can be handled by the cells before trig-
gering the cell death pathways, but once the maximum iron level is
overcome, the cell is indefectibly destined to die. Since iron overload
Fig. 3. Fluorescencemicroscopy of ATP13A2 andATP13A2-D508N cells stainedwith the lysosomotropic dye AO. (a) The cells were cultured on glassmultiwell plates for 48 h andwere then
incubatedwith 0 or 0.2mMCQ for 2 h at 37 °C before being stainedwith AO0.05 μM. The living cellswere directly observed by confocalmicroscopy (FluoView1000, Olympus, Japan)with
an appropriate AO ﬁlter. Bar, 10 μm. (b) Quantitative analysis of ATP13A2 and ATP13A2-D508N cells stained with AO indicates the increased size of acidic vesicles due to ATP13A2 over-
expression The vesicle size is expressed as the percentage of the mean vesicle area of ATP13A2-D508N cells (0.83 ± 0.06 μM2) calculated by the ImageJ Software program. **p b 0.01 sig-
niﬁcantly different from ATP13A2-D508N cells (Student's t test, GraphPad Prism 4, GraphPad Software, Inc.). (c) Quantitative analysis of ATP13A2 and ATP13A2-D508N cells treatedwith
CQ 0.2mM for 2 h at 37 °C before being stained with AO shows the increased size of acidic vesicles due to CQ exposure. The vesicle size is expressed as the percentage of the mean vesicle
area obtained for each cell type without CQ exposure (ATP13A2 = 1.69 ± 0.25 μM2, ATP13A2-D508N= 0.83 ± 0.06 μM2) calculated by the ImageJ Software program. (d) Electron mi-
croscopic examination of CHO cells stably expressing ATP13A2 or ATP13A2-D508N. Note in ATP13A2-expressing cells the enlargement of autolysosome-like structures (arrowheads) that
contain granular deposits. Mt, mitochondria; Nu, nucleus. Bar, 0.2 μm.
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determine the cell destiny, a non-linear correlation between iron accu-
mulation and viability is feasible. In this line, our results show that
ATP13A2 cells can better tolerate the iron overload under an iron
range of 0.25 to 1 mM in the culture medium.
We have recently shown that the expression of the human P5B-
ATPase ATP13A2 increases spermidine uptake in CHO cells [14]. Due
to their amino groups, polyamines like spermidine are able to chelate
metallic cations such as iron [35,36] maintaining it in a non-redox-ac-
tive form. Polyamine transport is initiated by an unidentiﬁed plasma
membrane carrier, and it is rapidly followed by sequestration into acidic
vesicles of the late endocytic compartment [37]. Thus, it can be con-
ceived that ATP13A2 cells containing larger lysosomes equipped with
more iron-chelating agents like polyamines are more efﬁcient at
preventing the LMP generated by iron-catalyzed Fenton reactions.
Supporting this hypothesis, here we found that acidic vesicles are en-
larged in ATP13A2-expressing CHO cells, and the iron-induced LMP
was also reduced in these cells. Accordingly, it was recently demonstrat-
ed that the overexpression of ATP13A2 produces a marked increase in
the diameter and number of autophagosomes [19], the primary
double-membrane vacuoles that engraft cytoplasmic proteins and
suborganelles, which are then fused to lysosomes for bulk degradation
in autophagy. A tempting explanation is that ATP13A2 expression may
promote the fusion of acidic vesicles promoting their size-increment.
Favoring this idea, it was recently published that autophagosomessurrounded by ATP13A2 were observed when the later stage(s) of au-
tophagy where inhibited [38]. This observation opens the possibility
that the P-type ATPase may be involved in the fusion of these entities
with lysosomes improving the autophagosomal ﬂux. Also worth men-
tioning is the fact that spermine prevents iron accumulation and de-
press lipofuscin (age pigment) formation in cultures myocardial cells
[39]. Lipofuscin is a non-degradable, iron-rich, autoﬂuorescent, poly-
meric compound that slowly accumulates within age in long-lived
postmitotic cells at a rate that inversely correlates with longevity [11,
40]. Even under normal conditions, iron-catalyzed peroxidation takes
place intralysosomally, resulting in the oxidative modiﬁcation of the
autophagocytosed material which becomes resistant to the hydrolytic
activity of lysosomal enzymes. If cells do not divide, this material pro-
gressively accumulates within the lysosomal compartment in the form
of lipofuscin inclusions [11]. A mutation of the ATP13A2 gene causes
neuronal ceroid lipofuscinosis, which comprises a heterogeneous
group of metabolic storage diseases that are characterized by the
accumulation of lipofuscin, neurodegeneration, and premature death
[41,42].
LMP is one of the ﬁrst events induced by iron overload and this is
followed by the release of cathepsins and other lysosome-resident en-
zymes from lysosomeswhich, depending on themagnitude of lysosom-
al rupture, triggers the apoptoticmechanism that leads to cell death [23,
27]. Accordingly, here we show that the LMP induced by iron treatment
evaluated by the AO relocation method or by measuring the activity of
Fig. 4. Lysosomemembrane permeabilization (LMP) detection byﬂuorescencemicroscopy inATP13A2 and ATP13A2-D508N cells. (a) Cellmonolayerswere incubated for 24 h at 37 °Cwith
0 or 0.3mMFeCl3 or plus 1.5 or 3mMH2O2 for 1 h in complete DMEMand stained for 10minwith AO 5 μg/ml. After threewashes in PBS, the living cells where excited at 473 nm, and the
green and red ﬂuorescence were directly observed by confocal microscopy (FluoView 1000, Olympus, Japan) as described in Section 2. Note the loss of the punctate red staining of acidic
organelles and/or increase of green ﬂuorescence after FeCl3 treatment and gain of the cytoplasmic red ﬂuorescence induced by H2O2 exposure in ATP13A2-D508N cells denoting the rup-
ture of lysosome integrity. Bar, 10 μm. Quantitative image analyses of (b) green and (c) red ﬂuorescence intensities. The ﬂuorescence intensity is expressed as the percentage of the ﬂuo-
rescence intensity obtained for each cell type without iron exposure calculated by using the ImageJ Software program (NIH). ***p b 0.001 and **p b 0.01 signiﬁcantly different from
untreated cells (Student's t test, GraphPad Prism 4, GraphPad Software, Inc.). (d) For the determination of the β-hexosaminidase activity of the cytosolic fraction, the cells were incubated
for 1.5 h at 37 °Cwith 1.5mM FeCl3 in complete DMEM, and the activity was determined in 50 μl of the cytosol fraction as described in Section 2. Values are expressed as the percentage of
the absorbance at 405 nmmeasured for untreated cells. A representative experiment of three independent experiments is shown, where each point is the mean ± SD of triplicate deter-
minations. *p b 0.1 signiﬁcantly different from untreated cells (Student's t test, GraphPad Prism 4, GraphPad Software, Inc.).
1652 D.E. Rinaldi et al. / Biochimica et Biophysica Acta 1848 (2015) 1646–1655the lysosome-resident β-hexosaminidase was reduced in ATP13A2
cells. An immediate event induced by the “lysosome content release”
is the actin cytoskeleton reorganization [34]. The actin cytoskeleton
plays a fundamental role in endocytosis and intracellular trafﬁcking
and is an essential component for the well-functioning of the lysosome
degradation pathway. Interestingly, here we found that the expression
of ATP13A2 also prevents the iron-induced actin cytoskeleton remodel-
ing. This modiﬁcation in the vesicle trafﬁcking may explain the in-
creased iron depositions observed in ATP13A2-D508N cells after 24 h
exposure.
Earlier studies suggested the involvement of the P5-ATPases in the
homeostasis of Ca2+ [5,43,44], Mn2+ [45,46], Ni2+ [47] and mostrecently Zn2+ [38,48]. Interestingly, all these cations can be related to
the development of PD [49–53], and the dysregulation of anyone of
them may alter the other's level. Moreover, the P5-ATPase associated
dysfunction of intracellular membrane compartments like the ER,
Golgi, and lysosome–endosome system could be either the cause or
the consequence of metal ion dyshomeostasis. Keeping this in mind,
the iron-protection induced by the expression of ATP13A2 could be
exerted through modiﬁcations of the cation transport. Nevertheless,
we found similar iron uptake or extrusion kinetics during the ﬁrst 3 h
in ATP13A2- or ATP13A2-D508N cells (data not shown). Hence, the
ATP13A2 protection against iron exposure seems to be exerted through
a mechanism that promotes the preservation of the lysosome integrity
Fig. 5. Fluorescence microscopy of the F-actin cytoskeleton in ATP13A2 and ATP13A2-D508N cells. The stably transfected cells were cultured on coverslips for 48 h. The cells were then in-
cubated under basal conditions (left panels) or with 1.5mMFeCl3 (right panels) for 1.5 h at 37 °C. The F-actin cytoskeletonwas stainedwith Phalloidin-TRITC (red), and the nucleus were
stained with Hoechst (blue) as described in Section 2. Merge images are shown in lower panels. Bar, 10 μm.
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lation of the cation transport kinetic. In this line, non-raft domains
enriched in phospholipids containing polyunsaturated fatty acids
(PUFAs) and vitamin E are more sensitive to lipid peroxidation than
lipid raft domains enriched in sphingolipids and cholesterol [54].
As the P-ATPases phylogenetically closest to the P5-ATPases are the
P4-ATPase phospholipid transporters [55], it has been speculated
that also the P5-ATPases may be involved in the active transport of
lipids [56]. Since the proper content and distribution of phospho-
lipids in themembrane is essential for the correct lysosome function,
further experiments examining the details of the lysosome mem-
brane composition of ATP13A2-expressing CHO cells may help to
reach a better understanding of its role in lysosome membrane
integrity.
Also worth mentioning is the fact that any change in lipid composi-
tion or distribution would modify the membrane functionality, altering
not only all the processes mediated by the membrane bilayers but also
the intra-organelle composition. Since manganese and zinc are able to
induce LMP [57,58] and the homeostasis of these cations are also mod-
iﬁed by ATP13A2 expression [38,45,46,48], we cannot exclude the pos-
sibility that the results shown here could be a general response to
metals rather than an speciﬁc iron effect. However we did not observe
any signiﬁcant difference between control cells and those expressing
the ATP13A2 pump in the viability of CHO cells treated with MnCl2
[13]. Moreover, several contradictory results were reported with the
same cations in different expression systems [57]. Further experiments
will help to evaluate the possible involvement of ATP13A2 in the re-
sponse to general osmolarity changes.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamem.2015.04.008.Transparency document
The Transparency Document associated with this article can be
found, in the online version.
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